- Abbott conducted several Scientific Workshops and Med Talks while also presenting 25 posters for its ARCHITECT and Alinity systems portfolio, and demonstrated the company's next generation of Alinity systems, GLP systems Track, AlinIQ Digital Health Solutions, Hematology, Molecular, Diabetes Care and PoC solutions. Abbott presented its i-STAT TBI plasma test, a rapid handheld traumatic brain injury (TBI) blood test, which aims to help clinicians assess individuals with suspected mild TBIs, including concussions. Sessions included Scientific Workshops: Blood-based Biomarkers for Traumatic Brain Injury (TBI); Med Talks: Biomarkers of Brain Injury, Making the Transition to HsTnI - Critical Challenges and Solutions, The Evolution of Artificial Intelligence and Machine Learning in Laboratory Medicine, New advancements in Molecular Diagnostics, The Future of Digital Health Solutions in the Lab, The Forefront of Innovation Using Biomarkers of Brain Injury, and early feedback from i-STAT TBI Plasma Users.
- Beckman Coulter showcased the new DxA 5000 Fit Workflow Automation System (for small and mid-sized labs); Clinical Informatics Solutions: DxONE Information Management Solutions (DxONE Inventory Manager, DxONE Workflow Manager, DxONE Command Central, DxONE Insights); Clinical Chemistry Analyzers: AU480 (for low to mid-volume hospitals and labs), DxC 700 AU (for mid to high-volume labs), and AU5800 Series (up to 2,000 tests per hour); and Hematology Solutions: DxH 900 (for high-volume labs), DxH 690T (5-part differential CBC analyzer), and DxH 560 AL. The company also gave a live presentation on sepsis diagnosis and management highlighting the use of standardized lab and clinical operations in the context of a patient’s journey from initial assessment in the Emergency Department (ED) through treatment in the Intensive Care Unit (ICU) to eventual discharge – ‘Clinical Evidence and Practical Implications of Monocyte Distribution Width (MDW)’.
- Cytovale revealed its USFDA 510(k) pending Cytovale system and 10-minute IntelliSep sepsis risk stratification test. The IntelliSep test aims to determine the risk of a patient having sepsis using a biomechanical evaluation of white blood cells from a standard blood draw at presentation, generating results in under 10 minutes. The company recently fulfilled target enrollment of the CV-SQuISH-ED study involving the IntelliSep test at four clinical study sites across the US and has included the data from that study in a 510(k) submission to FDA. The IntelliSep test was recently named an AACC Disruptive Technology Award semi-finalist.
- EDAN Instruments announced the launch of the POC blood gas and chemistry analysis system, i20, with parameters covering from blood gases, electrolyte, to CO-oximetry. The new system is designed for select patient care settings like intensive care units (ICUs), pulmonary units, emergency departments (EDs), operating rooms, neonatal intensive care, etc. Edan stated newly added analytes (tHb, sO2, FO2Hb, FHHb, FCOHb, FMetHb) on i20, are tailored to clinical applications of CO-oximetry, like poisoning or other clinical situations that alter Hb’s ability to carry oxygen.
- Roche introduced the Roche Idea Lab, where experts in areas critical to laboratory success provided key insights. These areas include a lab's success in health equity and testing access, staffing pressures, data optimization, and improving clinical outcomes for patients with cardio-metabolic, neuro-degenerative and infectious diseases. The company presented 11 interactive workshops as part of the Idea Lab to share best practices and provide answers on topics in the evolving lab environment. Roche also showcased 18 systems including the cobas pro and cobas pure serum work area solutions, cobas 5800 molecular system, and cobas pulse - a PoC glucose management solution.
- Siemens Healthineers unveiled the Atellica CI 1900 Analyzer, a clinical chemistry and immunoassay testing system and lower volume version of its on-the-market Atellica clinical chemistry and immunoassay testing solution. The system is in development and under review for potential clearance by the USFDA. The company also unveiled the Atellica CI Max System consisting of the Atellica CI analytical unit and sample handler. The system, which is also in development, has an integrated clinical chemistry and immunoassay annual capacity of more than 400,000 tests per year and an immunoassay annual workload of 40,000 tests per year.
- Sysmex showcased its offerings across Hematology, Urinalysis, Flow Cytometry testing technology and Information Systems. Some of the featured instruments included Hematology: XN-9100 Automated Hematology Analyzer (scalable, modular automation system), XN-L Automated Hematology Analyzers (for physicians’ offices and clinics), and CellaVision DC-1 Digital Cell Morphology Analyzer (for low-volume hematology labs); Urinalysis: UN-Series Automated Urinalysis Solution with Expanded Chemistry Functionality (fully scalable); Flow Cytometry: XF-1600 Flow Cytometer, and PS-10 Sample Preparation System; Informatics Solutions: Caresphere Workflow Solution (WS) - it will replace WAM 5.0 in 2025, and BeyondCare Quality Control Monitor (BCQM) - available for Hematology XN and XN-L Series and Urinalysis UN-Series. The company also conducted several webinars across multiple topics.
- Thermo Fisher Scientific showcased several technologies, assays and complement solutions for researchers developing new diagnostics. The company highlighted the Applied Biosystems TaqMan-SARS-CoV-2 Mutation Panel, which enables labs to build their own custom panel from a menu of verified real-time PCR assays; the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit; the new Thermo Scientific KingFisher SpeciTRAX Sample Transfer System, which provides researchers in infectious diseases and genetics with an automated sample-handling system and increased throughput; and a new interface with the Inpeco S.A.'s FlexLab Total Laboratory Automation system (TLA), that enables primary tubes on the Inpeco LAS to be transported directly to the Thermo Scientific Cascadion SM Clinical Analyzer for automated loading, pre-treatment and analysis. It also showcased several LC-MS/MS technologies and assays along the Thermo Scientific EliA RNA Pol III and EliA Rib-P tests that received USFDA clearance for aiding in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus.
EEMEA Marketing Team



